News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Spectral Diagnostics’s West Nile Virus Test Gets FDA Nod
December 12, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TORONTO, Dec 12 (Reuters) - Spectral Diagnostics Inc. (SDI.TO: Quote, Profile , Research) said on Tuesday its West Nile Virus test received marketing approval from the U.S. Food and Drug Administration.
>>>
Discuss This Story
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
MORE ON THIS TOPIC
Vaccines
FDA Pulls Valneva’s Chikungunya Shot From Market Citing ‘Serious Safety Concerns’
August 25, 2025
·
2 min read
·
Tristan Manalac
Regulatory
FDA To Publish Drug-Related Adverse Event Reports Daily
August 25, 2025
·
2 min read
·
Tristan Manalac
Approvals
Ionis Wins Approval For First RNA-Targeted Prophylactic for Rare Swelling Disease
August 22, 2025
·
2 min read
·
Tristan Manalac
Regulatory
After Court Win, Vanda Asks Makary To Review ‘Unacceptable’ Approval of Rival Generics
August 22, 2025
·
2 min read
·
Tristan Manalac
